Skip to content

Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri

Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01067027
Enrollment
50
Registered
2010-02-11
Start date
2009-06-30
Completion date
2012-06-30
Last updated
2011-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colic

Keywords

Colic, Colic in Breast-fed Infants

Brief summary

It is believed that probiotic Lactobacillus reuteri will improve the symptoms of breast-fed infants with colic.

Interventions

DIETARY_SUPPLEMENTLactobacillus reuteri

5 drops of study product 30 minutes before feeding.

Sponsors

Children's Investigational Research Program, LLC
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Days to 60 Days
Healthy volunteers
Yes

Inclusion criteria

* Ifants aged between 14 and 60 days * Breast fed, exclusively during length of trial * Diagnosis of infantile colic according to Wessel's criteria i.e paroxysmal fussing in infancy for more than three hours per day, at least three days per week. * Debut of colic symptoms 6+/-1 days before randomization * Gestational age between 37 and 42 weeks * Apgar score higher than 7 at 5 minutes * Mothers willing to follow a cows mild-free diet (free from mild, yoghurt, cheese etc) during the study period * Written informed consent from one or both parents * Stated availability throughout the study period

Exclusion criteria

* Major chronic disease * Gastrointestinal disease but controlled GERD with or without medication is not an

Design outcomes

Primary

MeasureTime frame
* Reduction of daily average crying time to less than 3 hours from baseline to the end of the study period as measured using a daily reporting of crying time by the parents.7, 14 and 21 days

Secondary

MeasureTime frame
Number of responders versus non-responders with L. reuteri versus placebo at end of the study.21 days

Countries

United States

Contacts

Primary ContactMisty R Ross, MA
mross@chirpresearch.com479-254-6772

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026